期刊文献+

膦甲酸钠干预高磷诱导的血管平滑肌细胞钙化的研究 被引量:1

Effect of phosphonoformic acid on vascular smooth muscle cell calcification induced by elevated phosphate
下载PDF
导出
摘要 目的 观察不同浓度的膦甲酸钠 (PFA)对高磷诱导的牛主动脉血管平滑肌细胞钙沉积和骨钙素 (OC)表达的影响。方法 用不同磷浓度 (正常磷Pi1.5mmol·L-1、高磷Pi2 0mmol·L-1)及含不同浓度膦甲酸钠的培养液 ,体外培养牛主动脉平滑肌细胞 ,观察血管平滑肌细胞钙沉积及骨钙素表达。用甲ο 酚酞络合酮方法测定钙含量 ,BCA法测定蛋白含量。培养上清液中骨钙素浓度用放射免疫法测定 ,用蛋白含量标化钙含量、骨钙素的浓度 ,RT PCR观察骨钙素mR NA的表达。结果 ①高磷组较正常磷组平滑肌细胞钙沉积增加 :细胞培养 6d后 ,高磷组 (77 187± 11 6 92 )mg·g-1Pro ,正常磷组 (2 5 76 8± 1 75 0 )mg·g-1Pro ,P <0 0 1;②膦甲酸钠能有效地抑制钙沉积 :培养 6d ,高磷 +PFA 1 0mmol·L-1组 (37 72 9± 5 899)mg·g-1Pro ,与高磷未干预组相比 ,P <0 0 1;③高磷组骨钙素表达明显增高。高磷组与正常磷组相比 ,培养上清液中骨钙素水平 :(1 5 0 3× 10 -2 ±2 6 0 1× 10 -3 )mg·g-1Pro对 (2 981× 10 -3 ± 8 382× 10 -4)mg·g-1Pro ,P <0 0 1;平滑肌细胞骨钙素mRNA表达 (OC/GAPDH) :1 886± 0 16 5对 0 75 2± 0 0 5 2 1,P <0 0 1;④膦甲酸钠能有效地抑制骨钙素的表达。高磷 +PFA 1 0mmol·L-1组与高磷组? AIM To observe the effect of phosphonoformic acid (PFA) in different concentration on vascular calcification induced by elevated phosphate. METHODS The cell culture of bovine aortic smooth muscle were performed. Calcium deposition in different phosphate and PFA concentrations were determined by O cresolphthalein complexone method, and osteocalcin expression by radioimmunity and RT PCR. RESULTS Compared to Pi 1 5 mmol·L -1 group,bovine smooth muscle cells (BSMC) cultured in medium containing Pi 2 0 mmol·L -1 phosphate level increased calcium deposition 〔On day 6, (77 187±11 692) mg·g -1 Pro versus (25 768±1 750) mg·g -1 Pro, P <0 01〕. Elevated phosphate treatment of BSMCs also enhanced osteocalcin expression 〔after 72 hour, Pi 2 0 mmol·L -1 group versus Pi 1 5 mmol·L -1 group: (1 503×10 -2 ±2 601×10 -3 ) mg·g -1 Pro versus (2 981×10 -3 ±8 382×10 -4 ) mg·g -1 Pro, P <0 01〕. PFA decreased ciacium deposition and osteocalcin expression statistically: ciacium deposition, (Pi 2 0+PFA1 0) mmol·L -1 group 〔(37 729±5 899) mg·g -1 Pro〕 versus Pi 2 0 mmol·L -1 group, P <0 01; osteocalcin: (Pi 2 0+PFA1 0) mmol·L -1 group 〔(4 529×10 -3 ±1 250×10 -3 ) mg·g -1 Pro〕 versus Pi 2 0 mmol·L -1 group, P <0 01, the same as osteocacin mRNA expression. CONCLUSION Elevated phosphate may directly stimulate calcium deposition and osteocalcin expression induced by elevated phosphate in vascular smooth muscle cell culture, and PFA had a negative regulation about this. PFA may be a new agent to treat vascular calcification induced by elevated phosphate.
出处 《中国药理学通报》 CAS CSCD 北大核心 2003年第3期344-347,共4页 Chinese Pharmacological Bulletin
关键词 血管平滑肌细胞 无机磷酸盐 钙化 骨钙素 膦甲酸钠 phosphate calcification smooth muscle cell osteocalcin phosphonoformic acid
  • 相关文献

参考文献10

  • 1[1]Block GA, Hulbert-Shearon TE. Association of serum phosphorus and calcium×phosphate product with mortality risk in chronic hemodialysis patients:A national study. Am J Kidney Dis, 1998;31:607~17
  • 2[2]Raggi P, Boulay A, Chasan-Taber S et al. Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease? J Am Coll Cardiol, 2002;39(4):695~701
  • 3[3]Giachelli CM,Jono S,Shioi A et al. Vascular calcification and inorganic phosphate. Am J Kidney Dis, 2001;38(5 Suppl 1):34~7
  • 4[4]Block GA, Port FK:Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: Recommol/Lendations for a change in management. Am J Kidney Dis, 2000;35(6):1226~37
  • 5[5]Uhlig K, Sarnak MJ, Singh AK. New approaches to the treatment of calcium and phosphorus abnormalities in patients on hemodialysis. Curr Opin Nephol Hypertens, 2001;10:793~8
  • 6[6]Moe SM, O'Neill KD, Duan D et al. Medial artery calcification in ESRD patients is associated with deposition of bone matrix proteins. Kidney Int, 2002;61(2):638~47
  • 7[7]Tintut Y,Dmer LL. Recent advances in multifactorial regulation of vascular calcification. Curr Opin Lipidol, 2001;12:555~60
  • 8[8]Matthew R. Davies and Keithh A. Hruska:Pathophysiological mechanisms of vascular calcifcation in end-stage renal disease. Kidny Int, 2001;60:472~9
  • 9[9]Shuichi Jono, Marc D, McKee Charles E et al. Phosphate regulation of vascular smooth muscle cell calcification. Circ Res, 2000;87:10~7
  • 10[10]Loghman-Adham M. Use of phosphonocarboxylic acids as inhibitors of sodium-phosphate cotransport. Gen Pharmacol, 1996;27(2):305~12

同被引文献10

  • 1郭峰,朱炳阳,迟秀玲,黄红林.迷迭香酸抗过氧化氢诱导血管平滑肌细胞凋亡作用的研究[J].中国药理学通报,2007,23(3):365-370. 被引量:26
  • 2Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s[ J]. Nature, 1993,362:801 - 9.
  • 3Ross R. The smooth muscle cell. Ⅱ. Growth of smooth muscle in culture and formation of elastic fibers [ J]. J Cell Biol, 1971,50 (1):172-86.
  • 4Chamley-Campbell J,Campell G R, Ross R. Smooth musle cell in culture [ J ]. Physiol Rev, 1979 ,59 ( 1 ) : 1 - 61.
  • 5Harder D R,Sperelakis N. Action potential generation in reaggregates of rat aortic smooth muscle cells in primary culture [ J ]. Blood Vessels, 1979,16 ( 4 ) : 186 - 201.
  • 6Wakino S, Kintseher U, Kim S,et al. Retinoids inhibit proliferation of human coronary smooth muscle cells by modulating cell cycle regulators [ J ]. A rterioscler Thromb Vasc Biol, 2001,21 ( 5 ) :746 - 51.
  • 7Thyberg J, Blomgren K, Roy J, et at. Phenotypic modulation of smooth muscle cells after arterial injury is associated with changes in the distribution of laminin and fibronectiu[ J]. J Histochem Cytochem, 1997,45 (6) :837 - 46.
  • 8Newby A C. Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture [ J]. Physiol Rev,2005,85( 1 ) :1 -31.
  • 9John S B. Cell separation : methods and selected applications [M ]. New York : Academic Press Inc, 1984:3.
  • 10杨军,林曙光,余细勇,唐其东.转化生长因子α联结saporin对平滑肌细胞和内皮细胞具有选择性的细胞毒作用[J].中国药理学通报,2002,18(2):148-152. 被引量:1

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部